Skip to main content
NIH funding notice RFA-CA-16-003

Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)

Closed on September 26, 2016.

Posted
December 9, 2015
Close date
September 26, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $371,340 in first-year total cost, median $185,670.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 TCRB-Q (O4)]1
  2. Special Emphasis Panel[ZCA1 TCRB-T (M2)]1

Most frequent institutions

  1. UNIVERSITY OF NORTH DAKOTA1
  2. UNIVERSITY OF PENNSYLVANIA1
Competing awards under RFA-CA-16-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Determining and enhancing metabolite fitness for metabolomics measurements1R21CA213234-01WELJIE, AALIM MUNIVERSITY OF PENNSYLVANIA, PA$197,590ZCA1
2017Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments.1R21CA217751-01NECHAEV, SERGEIUNIVERSITY OF NORTH DAKOTA, ND$173,750ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.